The DRC has improved testing capacity for Ebola, with two facilities operating in or near the epicenter. But this still may not be enough to keep up with a rapidly expanding disease.
OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today announced U.S. Food and Drug Administration (FDA) ...
Discover expert insights into Cushing's syndrome diagnosis using salivary cortisone testing and LC-MS/MS for improved accuracy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results